Efficacy of a medication management service in improving adherence to tyrosine kinase inhibitors and clinical outcomes of patients with chronic myeloid leukaemia: a randomised controlled trial

Efficacy of a medication management service in improving adherence to tyrosine kinase inhibitors and clinical outcomes of patients with chronic myeloid leukaemia: a randomised controlled trial

Purpose: Suboptimal adherence to tyrosine kinase inhibitors (TKIs) contributes to poor clinical outcomes in chronic myeloid leukemia (CML). This randomised controlled trial (RCT) aimed to evaluate the impact of a medication management service (MMS) on adherence to TKIs and clinical outcomes. Methods...

Full description

Bibliographic Details
Main Authors:	Tan, Bee Kim, Chua, Siew Siang, Chen, Li-Chia, Chang, Kian Meng, Balashanker, Sharmini, Bee, Ping Chong
Format:	Article
Published:	Springer Verlag (Germany) 2020
Subjects:	R Medicine

Similar Items

Medication-related issues associated with adherence to long-term tyrosine kinase inhibitors for controlling chronic myeloid leukemia: a qualitative study
by: Tan, B.K., et al.
Published: (2017)

Simvastatin enhances the efficacy of Bcr-Abl tyrosine kinase inhibitor nilotinib in chronic myeloid leukemia.
by: Koh, Yanqing.
Published: (2011)

High resolution melt curve analysis as a tool for screening tyrosine kinase domain mutations in patients with chronic myeloid leukemia on tyrosine kinase inhibitors
by: Ang, C.H., et al.
Published: (2010)

Real‐world tyrosine kinase inhibitor treatment pathways, monitoring patterns and responses in patients with chronic myeloid leukaemia in the United Kingdom: the UK TARGET CML study
by: Milojkovic, D, et al.
Published: (2020)

An update on imatinib mesylate therapy in chronic myeloid leukaemia patients in a teaching hospital in Malaysia
by: Bee, P.C., et al.
Published: (2012)

Characterizing drug resistance in hypoxia-adapted chronic myeloid leukaemia cells.
by: Muhammad Rauzan Rafman.
Published: (2013)

Rac inactivation decreases cell adhesion strength in chronic myeloid leukaemia
by: Yang, Joan Xiaohui
Published: (2011)

The cytotoxicity effect of ant-444 in human chronic myeloid leukaemia cells (K 562)
by: Khalid, Nor Bahijah, et al.
Published: (2013)

Severe cytopenias associated with the sequential use of busulphan and interferon-alpha in chronic myeloid leukaemia.
by: Shepherd, P, et al.
Published: (1994)

Interferon-alpha therapy in chronic myeloid leukaemia is probably better than hydroxyurea alone.
by: Allan, N, et al.
Published: (1995)

Discovery of a potent and selective DDR1 receptor tyrosine kinase inhibitor.
by: Kim, H, et al.
Published: (2013)

Efficacy of dendritic cell-based vaccine on acute myeloid leukaemia in a murine model
by: Ng, Wei Yi
Published: (2013)

Adaptive therapy to circumvent drug resistance to tyrosine kinase inhibitors in cancer: is it clinically relevant?
by: Hamdi, Amir Imran Faisal, et al.
Published: (2022)

C/EBPalpha mutations in acute myeloid leukaemias.
by: Nerlov, C
Published: (2004)

Selection of reference genes for quantitative studies in acute myeloid leukaemia
by: Lee, Cindee, et al.
Published: (2019)

hTERT, the catalytic component of telomerase, is downregulated in the haematopoietic stem cells of patients with chronic myeloid leukaemia.
by: Campbell, L, et al.
Published: (2006)

Chronic neutrophilic leukaemia.
by: Gan, G.G., et al.
Published: (2007)

Less utilized prognostic markers in acute myeloid leukaemia
by: Abdullah, Maha
Published: (2016)

Alternative splicing in human myeloid cell differentiation and leukaemia
by: Lim, Kai Yi
Published: (2021)

ENPP4 and HOXA3 as potential leukaemia stem cell markers in acute myeloid leukaemia
by: Mohd Amin, A, et al.
Published: (2023)

Recently targeted kinases and their inhibitors - the path to clinical trials
by: Knapp, S, et al.
Published: (2014)

Interferon alfa versus chemotherapy for chronic myeloid leukemia: a meta-analysis of seven randomized trials: Chronic Myeloid Leukemia Trialists' Collaborative Group.
by: Richards, S
Published: (1997)

Imatinib mesylate in the treatment of chronic myeloid leukemia: a local experience
by: Bee, P.C., et al.
Published: (2006)

Plasma and cell lysate proteins associated with treatment outcome in acute myeloid leukaemia
by: Barantalab, Fatemeh, et al.
Published: (2020)

Proteomic profile of acute myeloid leukaemia: a review update
by: Almaiman, Amer Abdulrahman, et al.
Published: (2016)

Identification of differentially expressed proteins as biomarkers of acute myeloid leukaemia
by: Barantalab, Fatemeh
Published: (2014)

Recent advances in diagnosis of acute myeloid leukaemia : a review.
by: Ambayya, Angeli, et al.
Published: (2013)

Transformation of myelodysplastic syndrome (MDS) to acute myeloid leukaemia (AML)
by: Goh, Chermaine Yu Zhen
Published: (2021)

Imatinib resistance and blast transformation of chronic myeloid leukemia associated with a novel tri-nucleotide insertion mutation of BCR-ABL kinase domain at position K294
by: Nadarajan, V.S., et al.
Published: (2012)

Genetic determinants excluding GBCR::ABL mutations of imatinib mesylate therapy response among chronic myeloid leukaemia patients in Malaysia
by: Ismail, Siti Mariam
Published: (2023)

Moringa oleifera leaf ethanol extract immunomodulatory activity discriminates between chronic myeloid leukaemia cell line and normal lymphocytes
by: Lawal, Hamza, et al.
Published: (2022)

Multivariate studies of receptor tyrosine kinase function in cancer
by: Wagner, Joel Patrick
Published: (2013)

The efficacy and safety of intramuscular injections of methylcobalamin in patients with chronic nonspecific low back pain: a randomised controlled trial
by: Chiu, C.K., et al.
Published: (2011)

A man with concomitant polycythaemia vera and chronic myeloid leukemia: the dynamics of the two disorders
by: Bee, P.C., et al.
Published: (2010)

Successful pregnancy with epidermal growth factor receptor tyrosine kinase inhibitor treatment of metastatic lung adenocarcinoma presenting with respiratory failure
by: Lee, C.H., et al.
Published: (2011)

The receptor tyrosine phosphatase Ptp69D and the receptor tyrosine kinase Pvr in Drosophila nervous system development
by: Robertson Sears, Heather C., 1975-
Published: (2006)

Cell viability of acute myeloid leukaemia blasts in culture correlates with treatment outcome
by: Abdullah, Maha, et al.
Published: (2008)

Distinctive patterns of microRNA expression associated with karyotype in acute myeloid leukaemia.
by: Dixon-McIver, A, et al.
Published: (2008)

Hydration effects on the efficacy of the Epidermal growth factor receptor kinase inhibitor afatinib
by: Kannan, Srinivasaraghavan, et al.
Published: (2017)

The PIM Kinase Inhibitor K00135 Sensitizes Primary Acute Lymphoblas tic Leukaemia (ALL) Cells to DNA Damaging Agents
by: Da Costa, D, et al.
Published: (2010)